Vertex Pharmaceuticals, Inc. (VRTX)
438.71
-8.55
(-1.91%)
USD |
NASDAQ |
Apr 02, 16:00
438.30
-0.41
(-0.09%)
After-Hours: 20:00
Vertex Pharmaceuticals Shareholders Equity (Quarterly) : 18.67B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 22.70B |
| Amgen, Inc. | 8.658B |
| Moderna, Inc. | 8.65B |
| Eli Lilly & Co. | 26.54B |
| Regeneron Pharmaceuticals, Inc. | 31.26B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 26.14B |
| Total Liabilities (Quarterly) | 7.477B |
| Debt to Equity Ratio | 0.1091 |
| Current Ratio | 2.901 |
| Net Debt Paydown Yield | -0.06% |